Publications by authors named "Ralph Toelg"

Claim this Profile
S
Serial quantitative flow ratio measurements of a successfully recanalized coronary chronic total occlusion.
Mohamed Samy, Abdelhakim Allali, Sultan Alotaibi, Ralph Toelg, Volker Geist

Int J Cardiol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative flow ratio of the donor coronary artery supplying a chronic total occlusion territory.
Karim Elbasha, Sultan Alotaibi, Mohamed Samy, Nader Mankerious, Ralph Toelg

Clin Res Cardiol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of coronary artery tortuosity on outcomes following stenting with newer-generation drug-eluting stents. An analysis of the randomized BIOFLOW trials.
Nader Mankerious, Ralph Toelg, Mohammad Abdelghani, Hector M Garcia-Garcia, Serdar Farhan

Rev Esp Cardiol (Engl Ed)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of the third-generation resorbable magnesium scaffold for coronary artery lesions: three-year results of the BIOMAG-I study.
Michael Haude, Adrian Wlodarczak, René J van der Schaaf, Jan Torzewski, Bert Ferdinande, Ralph Toelg

EuroIntervention· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One- versus three-month DAPT after everolimus-eluting stent implantation in diabetic patients at high bleeding risk: results from the XIENCE Short DAPT programme.
Angelo Oliva, Dominick J Angiolillo, Marco Valgimigli, Davide Cao, Samantha Sartori, Ralph Toelg

EuroIntervention· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1-Month or 3-Month DAPT in Women and Men at High Bleeding Risk Undergoing PCI.
Vijay Kunadian, Mauro Gitto, Birgit Vogel, Samantha Sartori, Dominick J Angiolillo, Ralph Toelg

JACC Cardiovasc Interv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, characteristics, and outcome of noncardiac surgery following transcatheter aortic valve implantation.
Sultan Alotaibi, Karim Elbasha, Mourad Bradai, Martin Landt, Arief Kurniadi, Ralph Toelg

Clin Res Cardiol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Trial of Biolimus DCB for In-Stent Restenosis: The Primary Results of the REFORM Study.
Robert A Byrne, Joo-Yong Hahn, Peter O'Kane, Manel Sabaté, Ralph Toelg

JACC Cardiovasc Interv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
ProGlide-AngioSeal versus ProGlide-FemoSeal for vascular access hemostasis posttranscatheter aortic valve implantation.
Mohamed Samy, Martin Landt, Nader Mankerious, Arief Kurniadi, Sultan Alotaibi, Ralph Toelg

Catheter Cardiovasc Interv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten-year Durability, Hemodynamic Performance, and Clinical Outcomes after Transcatheter Aortic Valve Implantation Using a Self-expanding Device.
Karim Elbasha, Jatinderjit Kaur, Mohammad Abdelghani, Martin Landt, Sultan Alotaibi, Ralph Toelg

Cardiol Ther· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular response following implantation of the third-generation drug-eluting resorbable coronary magnesium scaffold: an intravascular imaging analysis of the BIOMAG-I first-in-human study.
Masaru Seguchi, Alp Aytekin, Erion Xhepa, Michael Haude, Adrian Wlodarczak, Ralph Toelg

EuroIntervention· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease.
Nader Mankerious, Ralph Toelg, Birgit Vogel, Samantha Sartori, Dominick J Angiolillo

Am J Cardiol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of long-term adverse outcomes after successful chronic total occlusion intervention: physiology or morphology?
Karim Elbasha, Sultan Alotaibi, Hajo Heyer, Nader Mankerious, Ralph Toelg

Clin Res Cardiol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-hospital Outcomes of Rotational Atherectomy in ST-Elevation Myocardial Infarction: Results From the Multicentre ROTA-STEMI Network.
Rayyan Hemetsberger, Nader Mankerious, Guillem Muntané-Carol, Justin Temporal, Dmitriy Sulimov, Ralph Toelg

Can J Cardiol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower revascularization rates after high-speed rotational atherectomy compared to modified balloons in calcified coronary lesions: 5-year outcomes of the randomized PREPARE-CALC trial.
Nader Mankerious, Gert Richardt, Abdelhakim Allali, Volker Geist, Adnan Kastrati, Ralph Toelg

Clin Res Cardiol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of single- versus two-stent PCI technique in severely calcified true bifurcation lesions after rotational atherectomy.
Mohamed Samy, Ahmad Alali, Karim Elbasha, Danial Amoey, Rayyan Hemetsberger, Ralph Toelg

Clin Res Cardiol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes.
Davide Cao, Pascal Vranckx, Marco Valgimigli, Samantha Sartori, Dominick J Angiolillo, Ralph Toelg

EuroIntervention· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal changes in coronary plaque as assessed by an artificial intelligence-based optical coherence tomography: from the first-in-human trial on DREAMS 3G scaffold.
Hector M Garcia-Garcia, Ron Waksman, Gebremedhin D Melaku, Mohil Garg, Solomon Beyene, Ralph Toelg

Eur Heart J Cardiovasc Imaging· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Access Site on Periprocedural Bleeding and Cerebral and Coronary Events in High-Bleeding-Risk Percutaneous Coronary Intervention: Findings from the RIVA-PCI Trial.
Martin Borlich, Uwe Zeymer, Harm Wienbergen, Hans-Peter Hobbach, Alessandro Cuneo, Ralph Toelg

Cardiol Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1- Versus 3-Month DAPT in Older Patients at a High Bleeding Risk Undergoing PCI: Insights from the XIENCE Short DAPT Global Program.
Gennaro Sardella, Alessandro Spirito, Samantha Sartori, Dominick J Angiolillo, Pascal Vranckx, Ralph Toelg

Am J Cardiol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bleeding and Ischemic Risk Prediction in Patients With High Bleeding Risk (an EVOLVE Short DAPT Analysis).
Nino Mihatov, Ajay J Kirtane, Robert Stoler, Robert Feldman, Franz-Josef Neumann, Ralph Toelg

Am J Cardiol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI.
Marco Valgimigli, Alessandro Spirito, Samantha Sartori, Dominick J Angiolillo, Pascal Vranckx, Ralph Toelg

JACC Cardiovasc Interv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short Versus Long-Term Dual Antiplatelet Therapy in Patients at High Bleeding Risk Undergoing PCI in Contemporary Practice: A Systemic Review and Meta-analysis.
Nader Mankerious, Michael Megaly, Rayyan Hemetsberger, Abdelhakim Allali, Mohamed Samy, Ralph Toelg

Cardiol Ther· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study.
Michael Haude, Adrian Wlodarczak, René J van der Schaaf, Jan Torzewski, Bert Ferdinande, Ralph Toelg

EuroIntervention· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study.
Michael Haude, Adrian Wlodarczak, René J van der Schaaf, Jan Torzewski, Bert Ferdinande, Ralph Toelg

EClinicalMedicine· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis